Implantable cardiac monitors in cryptogenic stoke: Clarity or added uncertainty?
作者信息
Thiyagarajah Anand, Cheong Edmund, Lau Dennis H
机构信息
Department of Cardiology, Royal Adelaide Hospital, Adelaide, Australia.
Centre for Heart Rhythm Disorders, The University of Adelaide, Adelaide, Australia.
出版信息
Heart Rhythm O2. 2022 Apr 18;3(3):231-232. doi: 10.1016/j.hroo.2022.04.002. eCollection 2022 Jun.
Abstract
摘要
相似文献
1
Implantable cardiac monitors in cryptogenic stoke: Clarity or added uncertainty?隐源性卒中中的植入式心脏监测器：是明晰还是增加不确定性？
Heart Rhythm O2. 2022 Apr 18;3(3):231-232. doi: 10.1016/j.hroo.2022.04.002. eCollection 2022 Jun.
2
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation.用于检测隐源性卒中后房颤的植入式心脏监测器：系统评价与经济学评估
Health Technol Assess. 2020 Jan;24(5):1-184. doi: 10.3310/hta24050.
3
[Remote monitoring of implantable monitors : Towards coverage ? Evaluation of the procedure by the French National Authority for Health].[植入式监测器的远程监测：能否实现全面覆盖？法国国家卫生管理局对该程序的评估]
Ann Cardiol Angeiol (Paris). 2021 Nov;70(5):326-331. doi: 10.1016/j.ancard.2021.09.002. Epub 2021 Oct 7.
4
Effectiveness, utilisation and cost associated with implantable loop recorders versus external monitors after ischaemic or cryptogenic stroke.缺血性或不明原因卒中后植入式循环记录器与体外监测器的有效性、利用率和成本。
Open Heart. 2024 May 8;11(1):e002714. doi: 10.1136/openhrt-2024-002714.
5
Insertable cardiac monitors for detection of atrial fibrillation after cryptogenic stroke: a meta-analysis.可植入式心脏监测器在不明原因卒中后检测心房颤动的应用：一项荟萃分析。
Neurol Sci. 2021 Oct;42(10):4139-4148. doi: 10.1007/s10072-021-05104-6. Epub 2021 Feb 2.
6
Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial.基于植入式心脏监测仪的远程心脏医学风险评估在心肌梗死后合并自主神经功能障碍患者中的应用（SMART-MI-DZHK9）：一项前瞻性、研究者发起的、随机、多中心、开放标签、诊断性试验。
Lancet Digit Health. 2022 Feb;4(2):e105-e116. doi: 10.1016/S2589-7500(21)00253-3.
7
Age-Dependent Detection of Atrial Fibrillation with Implantable Cardiac Monitors in Patients with Cryptogenic Stroke.隐匿性卒中患者使用植入式心脏监测器进行房颤的年龄依赖性检测
TH Open. 2024 Apr 17;8(2):e202-e208. doi: 10.1055/s-0044-1786015. eCollection 2024 Apr.
8
Treatment of Cryptogenic Stroke Patients with Atrial Fibrillation Detected by Insertable Cardiac Monitors Reduces Recurrent Stroke Risk to Background Levels.通过植入式心脏监测器检测出患有心房颤动的隐源性卒中患者接受治疗后，复发性卒中风险可降至基线水平。
J Innov Card Rhythm Manag. 2021 Dec 15;12(12):4812-4817. doi: 10.19102/icrm.2021.121204. eCollection 2021 Dec.
9
Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors.间歇性房颤可能是导致不明原因卒中的主要原因之一：一项关于30天心脏事件监测仪的研究。
J Stroke Cerebrovasc Dis. 2009 May-Jun;18(3):185-9. doi: 10.1016/j.jstrokecerebrovasdis.2008.09.005.
10
Predictors of Atrial Fibrillation During Long-Term Implantable Cardiac Monitoring Following Cryptogenic Stroke.不明原因卒中后长期植入式心脏监测期间房颤的预测因素。
J Am Heart Assoc. 2020 Aug 4;9(15):e016040. doi: 10.1161/JAHA.120.016040. Epub 2020 Jul 21.
本文引用的文献
1
Longitudinal outcomes in cryptogenic stroke patients with and without long-term cardiac monitoring for atrial fibrillation.有或没有进行长期房颤心脏监测的隐源性卒中患者的纵向结局
Heart Rhythm O2. 2022 Feb 13;3(3):223-230. doi: 10.1016/j.hroo.2022.02.006. eCollection 2022 Jun.
2
New-generation miniaturized insertable cardiac monitor with a long sensing vector: Insertion procedure, sensing performance, and home monitoring transmission success in a real-world population.具有长传感向量的新一代小型化可插入式心脏监测器：在真实人群中的插入过程、传感性能及家庭监测传输成功率
Heart Rhythm O2. 2022 Jan 30;3(2):152-159. doi: 10.1016/j.hroo.2022.01.010. eCollection 2022 Apr.
3
Remote Monitoring of Implantable Loop Recorders: False-Positive Alert Episode Burden.植入式循环记录仪的远程监测：假阳性警报事件负担
Circ Arrhythm Electrophysiol. 2021 Nov;14(11):e009635. doi: 10.1161/CIRCEP.121.009635. Epub 2021 Oct 28.
4
Biomarkers in Atrial Fibrillation: Pathogenesis and Clinical Implications.心房颤动的生物标志物：发病机制与临床意义。
Card Electrophysiol Clin. 2021 Mar;13(1):221-233. doi: 10.1016/j.ccep.2020.10.006.
5
Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke.植入式心脏监测仪用于检测隐源性卒中患者心房颤动的成本效益
J Comp Eff Res. 2021 Feb;10(2):127-141. doi: 10.2217/cer-2020-0224. Epub 2020 Dec 10.
6
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.达比加群酯预防来源不明的栓塞性卒中后卒中
N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.
7
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.利伐沙班预防来源不明的栓塞性卒中后卒中
N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16.
8
Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis.无症状性设备检测到的心房颤动与卒中风险：系统评价和荟萃分析。
Eur Heart J. 2018 Apr 21;39(16):1407-1415. doi: 10.1093/eurheartj/ehx731.
9
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.ASSERT 中设备检测到的无症状性心房颤动持续时间与卒中发生情况。
Eur Heart J. 2017 May 1;38(17):1339-1344. doi: 10.1093/eurheartj/ehx042.
10
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.高凝状态导致心房纤维化，并促进心房颤动。
Eur Heart J. 2017 Jan 1;38(1):38-50. doi: 10.1093/eurheartj/ehw119. Epub 2016 Apr 12.
Zotero 插件